期刊文献+

胰岛素肺部给药系统研究进展 被引量:1

Research and Development of Insulin Formulations for Pulmonary Delivery System
下载PDF
导出
摘要 目的介绍胰岛素肺部给药系统的研究进展。方法综述了肺部给药机制、胰岛素吸入制剂/装置、药动学和药效学特点、临床应用等研究内容。结果与结论胰岛素肺部给药系统的发展用以补充和/或替代皮下注射,可能是一种有效方法,使患者获得更好地糖尿病治疗结果。 OBJECTIVE To introduce the research and development of insulin formulations for pulmonary delivery system.METHODS This review will discuss the mechanism of pulmonary delivery,inhaled insulin formulations/devices,pharmacokinetics and pharmacodynamics,the efficacy and safety of inhaled insulin in the treatment of diabetes. RESULTS and CONCLUSION The development of pulmonary insulin delivery to supplement and/or replace subcutaneous insulin injections may be an effective alternative,allowing patients to achieve intensive diabetes management.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2008年第z1期609-613,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 吸入胰岛素 肺部给药 inhaled insulin pulmonary delivery
  • 相关文献

参考文献31

  • 1洪天配,杨金奎.2006年国际糖尿病联盟第19届世界糖尿病大会专题报道[J].中国糖尿病杂志,2007,15(1):62-64. 被引量:50
  • 2[2]HARSCH I A.Inhaled insulins:their potential in the treatment of diabetes mellitus[J].Treat Endocrinol,2005;4(3):131-138. 被引量:1
  • 3[3]PATTON J S,BUKAR J G,Eldon MA.Clinical pharmacokinetics and pharmacodynamics of inhaled insulin[J].Clin Pharmacokinet,2004,43(12):781-801. 被引量:1
  • 4[4]USMANI OS,BIDDISCOMBE M F,BARMES PJ,Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size[J].2005,172(12):1 497-1 504. 被引量:1
  • 5[5]KATZ I M,SCHROETER J D,MARTONEN T B.Factors affecting the deposition of aerosolized insulin[J].2001,3(3):387-397 被引量:1
  • 6[6]DESHPANDE D S,BLANCHARD J D,Schuster J,et al.Gamma scintigraphic evaluation of a miniaturized AERx pulmonary delivery system for aerosol delivery to anesthetized animals using a positive pressure ventilation system[J].J Aerosol Med,2005,18(1):34-44. 被引量:1
  • 7[7]LENZER J.Inhaled insulin is approved in Europe and United States[J].BMJ,2006,332(7537):321. 被引量:1
  • 8[8]Pfizer Inc.Exubera(insulin human[J][rDNA origin]) inhalation powder:US package insert. 被引量:1
  • 9[9]FARR S J,McELDUFF A,MATHER L E,et al.Pulmonary insulin administration using the AERx System:physiological and physicochemical factors influencing insulin effectiveness in healthy fasting subjects[J].Diabetes Technol Ther,2000(2):185-197. 被引量:1
  • 10[10]CRAMER J A,OKIKAWA J,BELLAIRE S,et al.Compliance with inhaled insulin treatment using the AERx iDMS Insulin Diabetes Management System[J].Diabetes Technol Ther,2004,6(6):800-807. 被引量:1

共引文献49

同被引文献35

  • 1DUAN Xiao-pin,MAO Shi-rui.New strategies to im-prove the intranasal absorption of insulin[J].DrugDiscovery Today,2010,15(11-12):417-427. 被引量:1
  • 2HENKIN R I.Inhaled insulin Intrapulmonary,in-tranasal,and other routes of administration:Mecha-nisms of action[J].Nutrition,2010,26(1):33-39. 被引量:1
  • 3梁文权.生物药剂学与药物动力学:第2版[M].北京:人民卫生出版社,2004:71-72. 被引量:1
  • 4SHECHTER Y,MIRONCHIK M,RUBINRAUT S,etal.Reversible pegylation of insulin facilitates its pro-longed action in vivo[J].European Journal of Pharma-ceutics and Biopharmaceutics,2008,70(1):19-28. 被引量:1
  • 5AGARWAL V,REDDY I K,KHAN M A.Polymethyac-rylate based microparticulates of insulin for oral deliv-ery:Preparation and in vitro dissolution stability in thepresence of enzyme inhibitors[J].International Journalof Pharmaceutics,2001,225(1-2):31-39. 被引量:1
  • 6SIMON M,WITTMAR M,KISSEL T,et al.Insulin con-taining nanocomplexes formed by self-assembly frombiodegradable amine-modified poly(vinyl alcohol)-graft-poly(L-lactide):bioavailability and nasal tolera-bility in rats[J].Pharmaceutical Research,2005,22(11):1879-1885. 被引量:1
  • 7ZHANG Xin-ge,ZHANG Hui-jie,WU Zhong-ming etal.Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles[J].European Journal ofPharmaceutics and Biopharmaceutics,2008,68(3):526-534. 被引量:1
  • 8MAO Shi-rui,GERMERSHAUS O,FISCHER D,et al.Uptake and transport of PEG-graft-trimethyl-chitosan-copolymer-insulin nanocomplexes by epithelial cells[J].Pharmaceutical Research,2005,22(12):2058-2068. 被引量:1
  • 9DYER A M,HINCHCLIFFE M,WATTS P,et al.Nasaldelivery of insulin using novel chitosan based formula-tions:a comparative study in two animal models be-tween simple chitosan formulations and chitosan nanop-articles[J].Pharmaceutical Research,2002,19(7):998-1008. 被引量:1
  • 10VLLASALIU D,EXPOSITO H R,HERAS A,et al.Tight junction modulation by chitosan nanoparticles:Comparison with chitosan solution[J].InternationalJournal of Pharmaceutics,2010,400(1-2):183-193. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部